BACKGROUND: Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB. MATERIALS AND METHODS: Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection. RESULTS: CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay. CONCLUSION: Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.
BACKGROUND: Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB. MATERIALS AND METHODS:Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection. RESULTS: CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay. CONCLUSION: Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.
Authors: Rosario Menéndez; Antoni Torres; Rafael Zalacaín; Javier Aspa; Juan J Martín-Villasclaras; Luis Borderías; José M Benítez-Moya; Juan Ruiz-Manzano; Felipe Rodríguez de Castro; José Blanquer; Diego Pérez; Carmen Puzo; Fernando Sánchez-Gascón; José Gallardo; Carlos Alvarez; Luis Molinos Journal: Am J Respir Crit Care Med Date: 2005-06-03 Impact factor: 21.405
Authors: J Dorca; S Bello; J Blanquer; R de Celis; L Molinos; A Torres; A Verano; R Zalacain Journal: Arch Bronconeumol Date: 1997-05 Impact factor: 4.872
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: R Menéndez; A Torres; R Zalacaín; J Aspa; J J Martín Villasclaras; L Borderías; J M Benítez Moya; J Ruiz-Manzano; F Rodríguez de Castro; J Blanquer; D Pérez; C Puzo; F Sánchez Gascón; J Gallardo; C Alvarez; L Molinos Journal: Thorax Date: 2004-11 Impact factor: 9.139
Authors: I Alfageme; J Aspa; S Bello; J Blanquer; R Blanquer; L Borderías; C Bravo; R de Celis; X de Gracia; J Dorca; J Gallardo; M Gallego; R Menéndez; L Molinos; C Paredes; O Rajas; J Rello; F Rodríguez de Castro; J Roig; F Sánchez-Gascón; A Torres; R Zalacaín Journal: Arch Bronconeumol Date: 2005-05 Impact factor: 4.872
Authors: Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu Journal: Emerg Infect Dis Date: 2002-02 Impact factor: 6.883
Authors: Charlotte Mark Salomonsen; Mette Boye; Niels Høiby; Trine H Jensen; Anne Sofie Hammer Journal: Can J Vet Res Date: 2013-07 Impact factor: 1.310
Authors: Conrad Izydorczyk; Barbara Waddell; Brett D Edwards; Jasper Greysson-Wong; Michael G Surette; Ranjani Somayaji; Harvey R Rabin; John M Conly; Deirdre L Church; Michael D Parkins Journal: Front Microbiol Date: 2020-03-20 Impact factor: 5.640